Compile Data Set for Download or QSAR
Report error Found 212 Enz. Inhib. hit(s) with all data for entry = 9238
TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451282BDBM451282(US10709709, Example 109)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451280BDBM451280(US10709709, Example 107)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451281BDBM451281(US10709709, Example 108)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451278BDBM451278(US10709709, Example 105)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451276BDBM451276(US10709709, Example 103)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451277BDBM451277(US10709709, Example 104)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451274BDBM451274(US10709709, Example 101)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451275BDBM451275(US10709709, Example 102)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451273BDBM451273(US10709709, Example 100)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451298BDBM451298(US10709709, Example 125)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451299BDBM451299(US10709709, Example 126)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451294BDBM451294(US10709709, Example 121)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451292BDBM451292(US10709709, Example 119)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451293BDBM451293(US10709709, Example 120)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451286BDBM451286(US10709709, Example 113)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451312BDBM451312(US10709709, Example 139)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451306BDBM451306(US10709709, Example 133)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451307BDBM451307(US10709709, Example 134)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451304BDBM451304(US10709709, Example 131)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451302BDBM451302(US10709709, Example 129)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451303BDBM451303(US10709709, Example 130)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451301BDBM451301(US10709709, Example 128)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 50523661BDBM50523661(CHEMBL4547524 | US10709709, Example 154)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451341BDBM451341(US10709709, Example 170)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451360BDBM451360(US10709709, Example 190)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451361BDBM451361(US10709709, Example 191)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451354BDBM451354(US10709709, Example 184 | US10709709, Example 185)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451353BDBM451353(US10709709, Example 183)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451351BDBM451351(US10709709, Example 181)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451349BDBM451349(US10709709, Example 179)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451251BDBM451251(US10709709, Example 78)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451375BDBM451375(US10709709, Example 205)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451372BDBM451372(US10709709, Example 202)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451373BDBM451373(US10709709, Example 203)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 50523638BDBM50523638(CHEMBL4470815 | US10709709, Example 200)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 50523649BDBM50523649(CHEMBL4448266 | US10709709, Example 198)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451366BDBM451366(US10709709, Example 196)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451367BDBM451367(US10709709, Example 197)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451364BDBM451364(US10709709, Example 194)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451365BDBM451365(US10709709, Example 195)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451266BDBM451266(US10709709, Example 93)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451267BDBM451267(US10709709, Example 94)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 50523650BDBM50523650(CHEMBL4541232 | US10709709, Example 91)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451265BDBM451265(US10709709, Example 92)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 50523652BDBM50523652(CHEMBL4445368 | US10709709, Example 89)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451261BDBM451261(US10709709, Example 88)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451385BDBM451385(US10709709, Example 215 | US10709709, Example 216)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451385BDBM451385(US10709709, Example 215 | US10709709, Example 216)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 50523654BDBM50523654(CHEMBL4455651 | US10709709, Example 212)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 451383BDBM451383(US10709709, Example 213 | US10709709, Example 214)
Affinity DataIC50: 1nMAssay Description:Compounds were solubilized in DMSO and serially diluted, using 3-fold dilutions, into 100% DMSO at a concentration 50-fold greater than the desired a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

Displayed 1 to 50 (of 212 total ) | Next | Last >>
Jump to: